Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen Sodium ER Actual Use Study
NCT00751400Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Aprol in pain, sponsored by Bayer. Primary endpoint: Use Days With One or More Misuse Occasions at 1 month. Started Jul 2008; status: completed.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on NCT00751400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751400.